A 12-week, double-blind, randomised, placebo-controlled, multicentre trial to evaluate efficacy and tolerability of Antistax® film-coated tablets, 720mg/day orally, in male and female patients suffering from chronic venous insufficiency.
- Registry ID
- EUCTR2008-003932-40
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE3
- Sponsor
- Boerhinger Ingelheim Pharma GmbH & Co.KG
- Start date
- 2009-03-26
- Completion date
- 2009-11-17
- Last update
- 2026-08-16
Conditions
- chronic venous insufficiency
Summary
to assess the efficacy and tolerablity of Antistax® film-coated tablets in patients with chronic venous insufficiency (CVI, CEAP Classification: Clinical Class 3 and 4a)
Locations
View on source registry